← Back to Search

Acceptance and Commitment Therapy (ACT) for HIV/AIDS

N/A
Waitlist Available
Research Sponsored by University of California, San Diego
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 6 weeks
Awards & highlights

Study Summary

This study is evaluating whether a new type of therapy may help improve chronic pain for individuals with HIV.

Eligible Conditions
  • HIV/AIDS
  • Chronic Pain

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~6 weeks
This trial's timeline: 3 weeks for screening, Varies for treatment, and 6 weeks for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Change in Chronic Pain Acceptance Questionnaire (CPAQ) Week 0 to Week 6
Secondary outcome measures
Brief Pain Inventory Interference Subscale
Change in Chronic Pain Acceptance Questionnaire Week 0 to Week 3
Change in Pain Education Score

Trial Design

2Treatment groups
Experimental Treatment
Group I: Education ControlExperimental Treatment1 Intervention
Consists of eight weekly two hour group chronic pain education sessions led by trained lay personnel and followed by homework.
Group II: Acceptance and Commitment Therapy (ACT)Experimental Treatment1 Intervention
The intervention will consists of eight weekly two hour group ACT sessions led by trained lay personnel and followed by homework. ACT is a behavioral therapy.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Acceptance and Commitment Therapy (ACT)
2016
Completed Phase 3
~1460

Find a Location

Who is running the clinical trial?

University of California, San DiegoLead Sponsor
1,120 Previous Clinical Trials
1,521,394 Total Patients Enrolled
National Institute on Aging (NIA)NIH
1,671 Previous Clinical Trials
28,017,050 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Recent research and studies
JAIDS Journal of Acquired Immune Deficiency SyndromesJournal
Pain, Mood, and Substance Abuse in HIV
Merlin, Jessica S., Andrew O. Westfall, James L. Raper, Anne Zinski, Wynne E. Norton, James H. Willig, Robert Gross, Christine S. Ritchie, Michael S. Saag, and Michael J. Mugavero. 2012. “Pain, Mood, and Substance Abuse in HIV”. JAIDS Journal of Acquired Immune Deficiency Syndromes. Ovid Technologies (Wolters Kluwer Health). doi:10.1097/qai.0b013e3182662215.
The Journal of PainJournal
Core Outcome Domains and Measures for Pediatric Acute and Chronic/recurrent Pain Clinical Trials: Pedimmpact Recommendations
McGrath, Patrick J., Gary A. Walco, Dennis C. Turk, Robert H. Dworkin, Mark T. Brown, Karina Davidson, Christopher Eccleston, et al.. 2008. “Core Outcome Domains and Measures for Pediatric Acute and Chronic/recurrent Pain Clinical Trials: Pedimmpact Recommendations”. The Journal of Pain. Elsevier BV. doi:10.1016/j.jpain.2008.04.007.
Journal of the American Geriatrics SocietyJournal
American Geriatrics Society 2015 Updated Beers Criteria for Potentially Inappropriate Medication Use in Older Adults
By the American Geriatrics Society 2015 Beers Criteria Update Expert Panel. 2015. “American Geriatrics Society 2015 Updated Beers Criteria for Potentially Inappropriate Medication Use in Older Adults”. Journal of the American Geriatrics Society. Wiley. doi:10.1111/jgs.13702.
clinicaltrials.govStudy
Acceptance and Commitment Therapy for Aging People Living With HIV in Chronic Pain
Maile Young Karris 2019. "Acceptance and Commitment Therapy for Aging People Living With HIV in Chronic Pain". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT03699020.
~2 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top